ALEXANDER LAZAR to Hafnium
This is a "connection" page, showing publications ALEXANDER LAZAR has written about Hafnium.
Connection Strength
0.171
-
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial. Lancet Oncol. 2019 08; 20(8):1148-1159.
Score: 0.171